These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1116571)

  • 21. Kinetics of sickling of intact erythrocytes.
    Mizukami H; Adams B
    Prog Clin Biol Res; 1978; 21():159-75. PubMed ID: 662890
    [No Abstract]   [Full Text] [Related]  

  • 22. Sickle hemoglobin polymerization in solution and in cells.
    Noguchi CT; Schechter AN
    Annu Rev Biophys Biophys Chem; 1985; 14():239-63. PubMed ID: 3890882
    [No Abstract]   [Full Text] [Related]  

  • 23. Carbamyl phosphate mediated inhibition of the sickling of erythrocytes in vitro.
    Kraus LM; Kraus AP
    Biochem Biophys Res Commun; 1971 Sep; 44(6):1381-7. PubMed ID: 4946263
    [No Abstract]   [Full Text] [Related]  

  • 24. Prostaglandin E2 effects on oxygen affinity by sickle erythrocytes.
    Rabinowitz I; Wolf PL; Shikuma N; Berman S
    Prostaglandins; 1974 Aug; 7(4):309-17. PubMed ID: 4415346
    [No Abstract]   [Full Text] [Related]  

  • 25. Viscosity and gelation studies in deer hunting hemoglobins.
    Wong SC; Huisman TH
    Proc Soc Exp Biol Med; 1975 Dec; 150(3):581-4. PubMed ID: 1208578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between the oxygen affinity and in vitro sickling propensity of carbamylated sickle erythrocytes.
    Diederich D
    Biochem Biophys Res Commun; 1972 Feb; 46(3):1255-61. PubMed ID: 5012168
    [No Abstract]   [Full Text] [Related]  

  • 27. Urea, urease, cyanate, and the sickling of hemoglobin S.
    Nalbandian RM; Nichols BM; Stehouwer EJ; Camp FR
    Clin Chem; 1972 Sep; 18(9):961-4. PubMed ID: 5052097
    [No Abstract]   [Full Text] [Related]  

  • 28. Sickle cell disease: advances in the 1970s and challenge in the 1980s.
    Bunn HF
    Am J Pediatr Hematol Oncol; 1982; 4(2):166-71. PubMed ID: 6180652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dimethyl adipimidate: a new antisickling agent.
    Lubin BH; Pena V; Mentzer WC; Bymun E; Bradley TB; Packer L
    Proc Natl Acad Sci U S A; 1975 Jan; 72(1):43-6. PubMed ID: 1054514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oxygen affinity independent action of cyanate and 2,3 DPG on sickling.
    Jensen MC; Bunn HF; Halikas GC; Nathan DG
    Adv Exp Med Biol; 1972; 28():297-302. PubMed ID: 5085173
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment with NS3623, a novel Cl-conductance blocker, ameliorates erythrocyte dehydration in transgenic SAD mice: a possible new therapeutic approach for sickle cell disease.
    Bennekou P; de Franceschi L; Pedersen O; Lian L; Asakura T; Evans G; Brugnara C; Christophersen P
    Blood; 2001 Mar; 97(5):1451-7. PubMed ID: 11222393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies on the mechanism of action of cyanate in sickle cell disease. Oxygen affinity and gelling properties of hemoglobin S carbamylated on specific chains.
    Nigen AM; Njikam N; Lee CK; Manning JM
    J Biol Chem; 1974 Oct; 249(20):6611-6. PubMed ID: 4421180
    [No Abstract]   [Full Text] [Related]  

  • 33. Deoxyhemoglobin S: solubility vs. erythrocyte sickling.
    Vedvick TS; Koenig HM; Itano HA
    Clin Biochem; 1975 Aug; 8(4):288-90. PubMed ID: 1157297
    [No Abstract]   [Full Text] [Related]  

  • 34. A temperature-dependent latent-period in the aggregation of sickle-cell deoxyhemoglobin.
    Malfa R; Steinhardt J
    Biochem Biophys Res Commun; 1974 Aug; 59(3):887-93. PubMed ID: 4411783
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of piracetam on sickle erythrocytes and sickle hemoglobin.
    Asakura T; Ohnishi ST; Adachi K; Ozguc M; Hashimoto K; Devlin MT; Schwartz E
    Biochim Biophys Acta; 1981 May; 668(3):397-405. PubMed ID: 7236716
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sickle cells modified by an osmotic pulse in the presence of inositol hexaphosphate have decreased intracellular hemoglobin concentration and decreased in vitro sickling without prolonged in vivo survival.
    Franco R; Barker-Gear R; Silberstein E; Mayfield G; Weiner M; Palascak J; Green R
    Adv Exp Med Biol; 1992; 326():325-31. PubMed ID: 1295319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Morphological and submicroscopic comparison of sickle erythrocytes of humans and deer.
    Simpson CF; Taylor WJ
    Ann N Y Acad Sci; 1974 Nov; 241(0):614-22. PubMed ID: 4139922
    [No Abstract]   [Full Text] [Related]  

  • 38. The mechanism of action of two anti-sickling agents: sodium cyanate and glyceraldehyde.
    Manning JM; Acharya AS
    Am J Pediatr Hematol Oncol; 1984; 6(1):51-4. PubMed ID: 6711764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanism of sickling in deer erythrocytes.
    Amma EL; Sproul GD; Wong S; Huisman TH
    Ann N Y Acad Sci; 1974 Nov; 241(0):605-13. PubMed ID: 4530684
    [No Abstract]   [Full Text] [Related]  

  • 40. The in-vitro inhibition of erythrocyte sickling by Biuret.
    Photiades DP; Khalil SA; Osamo NO; Obi JO
    Blut; 1974 Sep; 29(3):219-23. PubMed ID: 4416306
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.